Skip to main content

Closed

KYMR: Kymera Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-697.8%

ROIC-22.2%

Financially safe

Stretched

Debt / equity0.05×

Interest coverage-1508.9×

Current ratio10.81×

Kymera Therapeutics, Inc.

KYMRNASDAQ Global Market·USD·Closed

Kymera Therapeutics, Inc.

KYMRNASDAQ·USD·Closed

$103.40

−3.37%

$103.40

−$3.61 (3.37%)

52W Range

71thpctl

Volume

0.63×avg

Mkt Cap

8.51BUSD

P/E

-28.9TTM

Div Yield

–ann

52W Range

71thpctl

Volume

0.63×avg

Market Cap

8.51BUSD

P/E Ratio

-28.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings